Zymosan suppresses leukotriene C4synthase activity in differentiating monocytes: antagonism by aspirin and protein kinase inhibitors
Open Access
- 12 January 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (4), 1417-1427
- https://doi.org/10.1096/fj.10-175828
Abstract
Cysteinyl leukotrienes (cysLTs) are potent proinflammatory mediators with particular relevance for asthma. However, control of cysLT biosynthesis in the time period after onset of acute inflammation has not been extensively studied. As a model for later phases of inflammation, we investigated regulation of leukotriene (LT) C4 synthase (LTC4S) in differentiating monocytes, exposed for several days to fungal zymosan. Incubations with LTA4 revealed 20-fold increased LTC4S activity during differentiation of monocytic Mono Mac 6 (MM6) cells, which was reduced by 80% in the presence of zymosan (25 µg/ml, 96 h). Zymosan (48 h) similarly attenuated LTC4S activity of primary human monocyte-derived macrophages and dendritic cells. Several findings indicate phosphoregulation of LTC4S: increased activity during MM6 cell differentiation correlated with reduced phosphorylation of 70-kDa ribosomal protein S6 kinase (p70S6K), which could phosphorylate purified LTC4S; the p70S6K inhibitor rapamycin (20 nM) doubled LTC4S activity of undifferentiated MM6 cells, and protein kinase A and C inhibitors (H-89, CGP-53353, and staurosporine) reversed the zymosan-induced suppression of LTC4S activity. Finally, zymosan (48 h) up-regulated PGE2 biosynthesis, and aspirin (10 µM) or prostaglandin E2 (PGE2) receptor antagonists counteracted the zymosan effect. Our results suggest a late PGE2-mediated phosphoregulation of LTC4S during microbial exposure, which may contribute to resolution of inflammation, with implications for aspirin hypersensitivity.—Esser, J., Gehrmann, U., Salvado, M. D., Wetterholm, A., Haeggstrom,J. Z., Samuelsson, B., Gabrielsson, S., Scheynius, A., Râdmark, O. Zymosan suppresses leukotriene C4 synthase activity in differentiating monocytes: antagonism by aspirin and protein kinase inhibitors. FASEBJ. 25, 1417–1427 (2011). www.fasebj.orgKeywords
Funding Information
- Vetenskapsrådet
- European Commission (FP7-Health-201668)
- Vårdalstiftelsen
- Karolinska Institutet
- Astma- och Allergiförbundet
- Hjärt-Lungfonden
- Karolinska Institutet
This publication has 59 references indexed in Scilit:
- PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous diseaseBlood, 2010
- A Critical Role for LTA 4 H in Limiting Chronic Pulmonary Neutrophilic InflammationScience, 2010
- An update on the role of leukotrienes in asthmaCurrent Opinion in Allergy and Clinical Immunology, 2010
- Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis*Published by Elsevier BV ,2010
- Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammationProceedings of the National Academy of Sciences of the United States of America, 2009
- Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signalingThe Journal of Experimental Medicine, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2α activationBlood, 2007
- Fungal zymosan induces leukotriene production by human mast cells through a dectin-1–dependent mechanismJournal of Allergy and Clinical Immunology, 2006
- Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2Biochemical Journal, 2006